The pandemic has forced healthcare teams to work together differently, spurring the widespread use of virtual communication tools including video calls, instant messaging and virtual whiteboards. But biotechnology and pharmaceutical companies have been slower to adopt virtual collaboration despite the potential to connect and innovate better and faster. In this episode of Healthcare Insider, we discussed the promise of virtual collaboration in biotech and pharma and how hybrid work is presenting new opportunities for innovation with Amelia Eudailey, healthcare industry lead at Zoom.